Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Advinus Therapeutics discovers new molecule for diabetes type 2

Sep. 14, 2010

Ono Pharma and Astellas submit minodronic acid MAA in Japan for osteoporosis

Sep. 14, 2010

Merck Frosst Canada presents new acyl-CoA desaturase inhibitors

Sep. 13, 2010

GFT-505 shows promise as antidiabetic agent in clinical study

Sep. 10, 2010

Santarus, S2 Therapeutics and VeroScience sign license agreement for Cycloset

Sep. 10, 2010

Taisho Pharmaceutical claims new selective SGLT1 inhibitors

Sep. 9, 2010

Merck & Co. discontinues development of MK-6913 for hot flashes

Sep. 9, 2010

New glucagon receptor antagonists claimed by Merck & Co.

Sep. 9, 2010

AstraZeneca identifies new histamine H3 receptor antagonists

Sep. 8, 2010

Banyu Pharmaceutical discloses new DGAT-1 inhibitors

Sep. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...